Veeda Clinical Research Pvt Ltd
We are one of the largest Independent CROs in India with a scientific edge, technical skills and better foresight for BA BE Studies & Clinical trials; with an objective of becoming a catalyst for enhanced drug developments to facilitate better patient treatments.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Havas Life London
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…
Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs
Sciterion
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…
Streaming Well
Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual stories and interactive experiences that connect with people.
Uniphar
Uniphar Group is a trusted global partner to pharmaceutical, medtech, and supply chain and retail companies, working to improve patient access to medicines around the world.
Company Details
Latest Content from PMHub
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
White Papers and Resources | April 16, 2019 | Cuttsy + Cuttsy
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation.
The playbook of a ‘reluctant creative’
Press Releases | April 10, 2019 | Resonant Group
Are we all capable of being creative?
Clinical Trials Materials: Getting the Basics Right
White Papers and Resources | April 9, 2019 | Cuttsy + Cuttsy
For those unfamiliar with them, clinical trials can be rather bewildering. This presents problems when it comes to recruiting patients — how can we make sure they understand what they...
News: Research Partnership is listed in the Alantra Pharma Fast 50 annual report
White Papers and Resources | April 9, 2019 | Inizio
The best performing privately-owned UK pharmaceutical businesses were revealed earlier this month with the publication of Pharma Times’ Alantra Pharma Fast 50 annual report.Read more about this report here
Event: Blending data science and market research at the Data Analytics & Insight conference
White Papers and Resources | April 9, 2019 | Inizio
Last month Analytics Director Misti Paul attended the Data Analytics & Insight Conference. In our latest blog post she reflects on the presentations that were given and what lessons can be...
Presentation: Optimize your digital assets with UX research
White Papers and Resources | April 9, 2019 | Inizio
US Director Liza Pliss recently presented the paper 'Optimize your digital assets with UX research' at the PMR Conference in New Jersey, USA. Don't worry if you missed it though,...
Report: Living With Rheumatoid Arthritis 2019 reports now available to purchase
White Papers and Resources | April 9, 2019 | Inizio
We have published new Living with Rheumatoid Arthritis reports in 5EU, Japan and Canada. The reports consist of 30-minute quantitative online and qualitative telephone interviews with RA patients. Read more on...
Infographic: Rheumatoid arthritis (RA)
White Papers and Resources | April 9, 2019 | Inizio
An overview of the RA biologic patientOur RA market snapshot offers an introduction to the real world patient data collected by our Therapy Watch RA study. The snapshot looks at...
Webcast: Navigating new frontiers: Ways to find space in the future RA market
White Papers and Resources | April 9, 2019 | Inizio
In partnership with pharmaphorumView the webcast »The emergence of low-cost biosimilar versions of Humira and the new janus kinase (JAK) inhibitors, are shaking up a once-stable market.Although there are only...
Live Webinar: China in the fast lane: How to play and win in the world’s hottest emerging market
White Papers and Resources | April 9, 2019 | Inizio
Tuesday 16th April 2019 10:00 EST/ 15:00 GMT / 16:00 CEST